-Wall Street Journal
HC Wainwright & Co. Initiates Coverage On Tango Therapeutics with Buy Rating, Announces Price Target of $10
HC Wainwright & Co. analyst Robert Burns initiates coverage on Tango Therapeutics (NASDAQ:TNGX) with a Buy rating and announces Price Target of $10.